Strata Oncology - Crunchbase Company Profile & Funding

Q: Who invested in Strata Oncology?

Strata Oncology has 13 investors including Wellington Management And Baird Capital.

Q: When was the last funding round for Strata Oncology?

Strata Oncology closed its last funding round on obfuscated from a Series C round.

Q: How much funding has Strata Oncology raised to date?

Strata Oncology has raised obfuscated.

Overview

Strata Oncology

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Strata Oncology

CB Rank

35275

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Founded

obfuscation

Private

Series C

Ann Arbor, Michigan, United States

51-100

www.strataoncology.com/

Biotechnology

Genetics

Health Care

Health Diagnostics

Medical Device

Oncology

Funding Rounds

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Dan Rhodes: Co-founder & CEO
Scott Tomlins: Chief Medical Officer, Co-Founder

Details

Legal Name

Strata Oncology Inc.

Operating Status

Active

Company Type

For Profit

Founders

Dan Rhodes, Keith Flaherty, Scott Tomlins

About the Company

Strata Oncology is a precision oncology company dedicated to transforming cancer care by expanding patient access to precision medicine clinical trials and accelerating drug approval.

Strata's national precision oncology platform serves the needs of patients, providers and drug developers by providing a link from patient screening to

streamlined enrollment in mutation-matched clinical trials. Follow us on Twitter @StrataOncology.

Phone Number

734-527-1000

Contact Email

partner@strataoncology.com

Predictions & Insights

Growth Insight

See this Growth Insight

Strata Oncology is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Strata Select

A molecular profiling test for advanced cancer patients that combines DNA and RNA sequencing to provide treatment selection guidance for immunotherapy and other therapies.

Immunotherapy Response Score (IRS)

A diagnostic tool that predicts the benefit of anti-PD-1/PD-L1 monotherapy by combining tumor mutation burden with the expression of specific genes.

Research & Development

Strata Oncology is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Strata Oncology	11	obfuscated obfuscation	Wellington Management	Series C
obfuscated obfuscation	Series C - Strata Oncology	11	obfuscated obfuscation	Wellington Management	Series C
obfuscated obfuscation	Series C - Strata Oncology	11	obfuscated obfuscation	Wellington Management	Series C
obfuscated obfuscation	Series C - Strata Oncology	11	obfuscated obfuscation	Wellington Management	Series C
obfuscated obfuscation	Series C - Strata Oncology	11	obfuscated obfuscation	Wellington Management	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Strata Oncology	11	obfuscated obfuscation	Wellington Management	Series C
obfuscated obfuscation	Series C - Strata Oncology	11	obfuscated obfuscation	Wellington Management	Series C
obfuscated obfuscation	Series C - Strata Oncology	11	obfuscated obfuscation	Wellington Management	Series C
obfuscated obfuscation	Series C - Strata Oncology	11	obfuscated obfuscation	Wellington Management	Series C
obfuscated obfuscation	Series C - Strata Oncology	11	obfuscated obfuscation	Wellington Management	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Wellington Management	Yes	Series C - Strata Oncology	—
Wellington Management	Yes	Series C - Strata Oncology	—
Wellington Management	Yes	Series C - Strata Oncology	—
Wellington Management	Yes	Series C - Strata Oncology	—
Wellington Management	Yes	Series C - Strata Oncology	—